253 related articles for article (PubMed ID: 20418665)
21. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.
Rattan R; Giri S; Hartmann LC; Shridhar V
J Cell Mol Med; 2011 Jan; 15(1):166-78. PubMed ID: 19874425
[TBL] [Abstract][Full Text] [Related]
22. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway.
Murase T; Misawa K; Haramizu S; Hase T
Biochem Pharmacol; 2009 Jul; 78(1):78-84. PubMed ID: 19447226
[TBL] [Abstract][Full Text] [Related]
23. Role of the LKB1/AMPK pathway in tumor invasion and metastasis of cancer cells (Review).
Li N; Huang D; Lu N; Luo L
Oncol Rep; 2015 Dec; 34(6):2821-6. PubMed ID: 26398719
[TBL] [Abstract][Full Text] [Related]
24. AMPK-Independent LKB1 Activity Is Required for Efficient Epithelial Ovarian Cancer Metastasis.
Buensuceso A; Ramos-Valdes Y; DiMattia GE; Shepherd TG
Mol Cancer Res; 2020 Mar; 18(3):488-500. PubMed ID: 31744879
[TBL] [Abstract][Full Text] [Related]
25. LKB1 Promotes the Transformation of Bone Marrow Mesenchymal Stem Cells into Adipocytes Under Oxidative Stress via AMPK-mTOR Signaling Pathway.
Jiang R; Yang T; Zhang Y; Wang Z; Zhang T
J Interferon Cytokine Res; 2020 Jul; 40(7):370-376. PubMed ID: 32634329
[TBL] [Abstract][Full Text] [Related]
26. LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
Trapp EK; Majunke L; Zill B; Sommer H; Andergassen U; Koch J; Harbeck N; Mahner S; Friedl TWP; Janni W; Rack B; Alunni-Fabbroni M
Mol Oncol; 2017 Nov; 11(11):1508-1526. PubMed ID: 28700115
[TBL] [Abstract][Full Text] [Related]
27. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
[TBL] [Abstract][Full Text] [Related]
28. Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.
Rivera Rivera A; Castillo-Pichardo L; Gerena Y; Dharmawardhane S
PLoS One; 2016; 11(6):e0157251. PubMed ID: 27285995
[TBL] [Abstract][Full Text] [Related]
29. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.
Dolinsky VW; Chan AY; Robillard Frayne I; Light PE; Des Rosiers C; Dyck JR
Circulation; 2009 Mar; 119(12):1643-52. PubMed ID: 19289642
[TBL] [Abstract][Full Text] [Related]
31. Tumor suppression by LKB1: SIK-ness prevents metastasis.
Shaw RJ
Sci Signal; 2009 Sep; 2(86):pe55. PubMed ID: 19724060
[TBL] [Abstract][Full Text] [Related]
32. Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.
Chen MB; Shen WX; Yang Y; Wu XY; Gu JH; Lu PH
J Cell Physiol; 2011 Jul; 226(7):1915-25. PubMed ID: 21506122
[TBL] [Abstract][Full Text] [Related]
33. Novel mutations and role of the LKB1 gene as a tumor suppressor in renal cell carcinoma.
Yalniz Z; Tigli H; Tigli H; Sanli O; Dalay N; Buyru N
Tumour Biol; 2014 Dec; 35(12):12361-8. PubMed ID: 25179843
[TBL] [Abstract][Full Text] [Related]
34. PIM kinases inhibit AMPK activation and promote tumorigenicity by phosphorylating LKB1.
Mung KL; Eccleshall WB; Santio NM; Rivero-Müller A; Koskinen PJ
Cell Commun Signal; 2021 Jun; 19(1):68. PubMed ID: 34193159
[TBL] [Abstract][Full Text] [Related]
35. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
Hawley SA; Boudeau J; Reid JL; Mustard KJ; Udd L; Mäkelä TP; Alessi DR; Hardie DG
J Biol; 2003; 2(4):28. PubMed ID: 14511394
[TBL] [Abstract][Full Text] [Related]
36. LKB1 regulated pathways in lung cancer invasion and metastasis.
Marcus AI; Zhou W
J Thorac Oncol; 2010 Dec; 5(12):1883-6. PubMed ID: 21102257
[TBL] [Abstract][Full Text] [Related]
37. 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol suppresses UV-Induced MMP-1 expression through AMPK-mediated mTOR inhibition as a downstream of the PKA-LKB1 pathway.
Shin DJ; Kim JE; Lim TG; Jeong EH; Park G; Kang NJ; Park JS; Yeom MH; Oh DK; Bode AM; Dong Z; Lee HJ; Lee KW
J Cell Biochem; 2014 Oct; 115(10):1702-11. PubMed ID: 24821673
[TBL] [Abstract][Full Text] [Related]
38. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
39. Evidence for LKB1/AMP-activated protein kinase/ endothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, S-adenosylmethionine, and nitric oxide in hepatocyte proliferation.
Vázquez-Chantada M; Ariz U; Varela-Rey M; Embade N; Martínez-Lopez N; Fernández-Ramos D; Gómez-Santos L; Lamas S; Lu SC; Martínez-Chantar ML; Mato JM
Hepatology; 2009 Feb; 49(2):608-17. PubMed ID: 19177591
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation.
Zheng B; Jeong JH; Asara JM; Yuan YY; Granter SR; Chin L; Cantley LC
Mol Cell; 2009 Jan; 33(2):237-47. PubMed ID: 19187764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
